Yes it does. Since the company was liquidated (i.e., everything of value sold), it means nothing of "monetary compensation" is left. This is why Bioamber told you in its last public press release (found here: https://sec.report/Document/0001193125-18-309191/) the following:
"The liquidation of the Company’s assets will result in little to no residual value for non-secured creditors, and no residual value for equity investors of the Company."
If you want me to similarly debunk this nonsense "interests to be applied at a non competitive rate" you will have to explain it further.
Market Data 
Markets 
AI
